REGENERON PHARMACEUTICALS - COM - Call

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,810
Holdings value
$1,017,709
% of all portfolios
0%
Number of holders
1
Number of sells
-1
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of REGENERON PHARMACEUTICALS - COM - Call

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,810 $1,017,709 -$213,100 $562.27 1
2025 Q2 2,189 $1,149,225 -$1,188,600 $525 1
2025 Q1 4,453 $2,824,226 $634.23 1
2024 Q4 4,453 $3,172,005 -$413,151 $712.33 1
2024 Q3 5,033 $1,956,412 $1,051.24 1
2024 Q2 $1,051.03 0
2024 Q1 $962.49 0
2023 Q4 $878.29 0
2023 Q3 $822.96 0
2023 Q2 0 $0 -$493,000 $718.54 0
2023 Q1 600 $493,000 +$493,000 $821.67 1
2022 Q4 $721.49 0
2022 Q3 $688.87 0
2022 Q2 $591.13 0
2022 Q1 $698 0
2021 Q4 $631.5 0
2021 Q3 $589.88 0
2021 Q2 $558.52 0
2021 Q1 $473.12 0
2020 Q4 $483.11 0
2020 Q3 $559.8 0
2020 Q2 $623.68 0
2020 Q1 $488.28 0
2019 Q4 0 $0 -$338,000 $375.49 0
2019 Q3 1,100 $338,000 +$338,000 $277.42 1
2019 Q2 $312.5 0
2019 Q1 $410.62 0
2018 Q4 $373.5 0
2018 Q3 $403.98 0
2018 Q2 $345 0
2018 Q1 $344.55 0
2017 Q4 $375.95 0
2017 Q3 $447.05 0
2017 Q2 $491.16 0
2017 Q1 $387.53 0
2016 Q4 $367.08 0
2016 Q3 $564.49 0
2016 Q2 $349.24 0
2016 Q1 $360.44 0
2015 Q4 0 $0 -$64,000 $542.87 0
2015 Q3 11,400 $64,000 +$64,000 $465.14 1
2015 Q2 $510.13 0
2015 Q1 $451.48 0
2014 Q4 $410.28 0
2014 Q3 $360.52 0
2014 Q2 $282.48 0
2014 Q1 $300.29 0